Several neuroimaging markers have been established for the early diagnosis of Alzheimer's disease, among them amyloid-beta deposition, glucose metabolism, and gray matter volume.
<clarity> Several neuroimaging markers have been established for the early diagnosis of Alzheimer's disease, among them amyloid-beta deposition, glucose metabolism, and gray matter volume.
A sequence of pathological changes takes place in Alzheimer's disease, among them amyloid-beta deposition, glucose metabolism, and gray matter volume.